HIGHLIGHTS
- who: Maysaa Abdulla and colleagues from the Department of Immunology, Genetics and Pathology, University have published the paper: Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases, in the Journal: Biomolecules 2023, 240 of 17/09/2020
- what: As a follow-up to a recent publication from the group, where higher proportions of PD-1+ cells and a tendency for lower proportions of PD-L1+ and Epstein-Barr virus (EBV) positive cells in benign lymphadenopathies from patients with AD were found, the aim of this study was to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.